ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 419681 | Rec_0432339 | ProTx-II (β/ω-theraphotoxin-Tp2a) |
YCQKWMWTCDSERKCCEGMVCRLWCKKKLW |
Thrixopelma pruriens [Animal] |
Toxin, Sodium channel inhibitor |
human NaV1.7 (SCN9A) expressed in HEK293 cells |
0.7 nM | IC50 (whole-cell voltage-clamp sodium-channel inhibition) |
20855463 | - |
YES |
| 419682 | Rec_0432340 | Arenicin variant V15H |
GFCWYVCVYRNGVRHCYRRCN |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 10536 |
- | plate clearing-zone antimicrobial screening in horse blood/serum |
- | US 2011/0306750 A1 |
YES |
| 419683 | Rec_0432341 | Bac2205 (SEQ ID 1535) |
RRWRIVVIRVTR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa H1001 |
- | luciferase-based antimicrobial screening |
- | US 2008/0207522 A1 |
YES |
| 419684 | Rec_0432342 | Bac2770 (SEQ ID 2100) |
RIWVNWRR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa H1001 |
- | luciferase-based antimicrobial screening |
- | US 2008/0207522 A1 |
YES |
| 419685 | Rec_0432343 | Bac2378 (SEQ ID 1708) |
RWWKIWVWRWWR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa H1001 |
- | luciferase-based antimicrobial screening |
- | US 2008/0207522 A1 |
YES |
| 419686 | Rec_0432344 | Tumor-homing peptide CGEGHPC |
CGEGHPC |
synthetic construct [Synthetic] |
Tumor Homing Peptide, Drug Delivery Vehicle, Anticancer targeting |
human 435 breast carcinoma xenograft in nude mice |
- | in vivo phage-display tumor-homing panning |
- | US 6,576,239 |
YES |
| 419687 | Rec_0432345 | Myelopeptide-1 (MP-1) |
FLGFPT |
Sus scrofa [Animal] |
Immunomodulatory |
NZB mouse spleen cells |
- | antibody-forming cell assay / ConA-induced spleen-cell proliferation |
8747719 | - |
YES |
| 419688 | Rec_0432346 | Myelopeptide-1 (MP-1) |
FLGFPT |
Sus scrofa [Animal] |
Immunomodulatory |
cyclophosphamide-treated (CBA×C57BL/6)F1 mice |
- | in vivo antibody-production assay |
8747719 | - |
YES |
| 419689 | Rec_0432347 | Frog neurotensin |
XAHISKARRPYIL |
Rana ridibunda [Animal] |
Neuropeptide, alpha-MSH release stimulation |
frog pars intermedia melanotrope cells |
5 nM | ED50 (alpha-MSH release perifusion assay) |
9751493 | - |
YES |
| 419690 | Rec_0432348 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat submandibular ganglion preganglionic cholinergic nerve terminals |
47 % | % inhibition of evoked EPSP amplitude at 100 nM |
12441339 | - |
YES |
| 419691 | Rec_0432349 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat CaV2.2 peripheral α1B-b (α1B alone) |
0.24±0.05 nM | Kd (two-electrode voltage-clamp kinetics in Xenopus oocytes) |
15166237 | - |
YES |
| 419692 | Rec_0432350 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat CaV2.2 peripheral α1B-b + β3 |
0.11±0.02 nM | Kd (two-electrode voltage-clamp kinetics in Xenopus oocytes) |
15166237 | - |
YES |
| 419693 | Rec_0432351 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat CaV2.2 peripheral α1B-b + β3 + α2δ |
15.6±2.6 nM | Kd (two-electrode voltage-clamp kinetics in Xenopus oocytes) |
15166237 | - |
YES |
| 419694 | Rec_0432352 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat CaV2.2 central α1B-d (α1B alone) |
0.16±0.02 nM | Kd (two-electrode voltage-clamp kinetics in Xenopus oocytes) |
15166237 | - |
YES |
| 419695 | Rec_0432353 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat CaV2.2 central α1B-d + β3 |
0.09±0.01 nM | Kd (two-electrode voltage-clamp kinetics in Xenopus oocytes) |
15166237 | - |
YES |
| 419696 | Rec_0432354 | [R10K]MVIIA (omega-conotoxin MVIIA analogue) |
CKGKGAKCSKLMYDCCTGSCRSGKC |
synthetic construct [Synthetic] |
Toxin, Ion channel blocker, Calcium channel blocker, N-type CaV2.2 inhibitor |
rat CaV2.2 central α1B-d + β3 + α2δ |
8.9±2.2 nM | Kd (two-electrode voltage-clamp kinetics in Xenopus oocytes) |
15166237 | - |
YES |
| 419697 | Rec_0432355 | navitoxin |
FSCDHSACAVRCLAQRRKGGKCKNGDCVCR |
synthetic construct [Synthetic] |
Toxin, Venom, Potassium channel blocker, Neurotoxin |
Kv1.3 potassium channel |
2900.6±125.3 nM | IC50 (electrophysiological voltage-clamp assay) |
24425781 | - |
YES |
| 419698 | Rec_0432356 | gamma1-MSH-amide |
YVMGHFRWDRF |
synthetic construct [Synthetic] |
Hormone, Neuropeptide, Receptor ligand, SNSR1/MrgC ligand |
HEK293 cells expressing rat SNSR1 (MrgC) |
63±22 nM | EC50 (FLIPR calcium assay) |
15118101 | - |
YES |
| 419699 | Rec_0432357 | gamma1-MSH-amide |
YVMGHFRWDRF |
synthetic construct [Synthetic] |
Hormone, Neuropeptide, Receptor ligand, SNSR1/MrgC ligand |
HEK293 cells expressing rat SNSR1 (MrgC) |
36±5 nM | Ki (radioligand competition binding) |
15118101 | - |
YES |
| 419700 | Rec_0432358 | gamma1-MSH-amide |
YVMGHFRWDRF |
synthetic construct [Synthetic] |
Hormone, Neuropeptide, Receptor ligand, SNSR1/MrgC ligand |
rat spinal cord membranes |
140±14 nM | Ki (radioligand competition binding) |
15118101 | - |
YES |